$CURR CURE Pharmaceutical Issues Letter to Shareho
Post# of 4481
(Total Views: 254)
Posted On: 11/20/2020 11:21:30 AM
$CURR CURE Pharmaceutical Issues Letter to Shareholders
November 18, 2020
Click here:
https://www.biospace.com/article/releases/cur...reholders/
About CURE Pharmaceutical Holding Corp.
CURE Pharmaceutical(R) is the pioneering developer of CUREform(TM), a patented drug delivery platform that offers a number of unique immediate- and controlled-release drug delivery vehicles designed to improve drug efficacy, safety, and patient experience for a wide range of active ingredients.
As a vertically integrated company, CURE's 25,000 square foot, FDA-registered, NSF(R) and cGMP-certified manufacturing facility enables it to partner with pharmaceutical and wellness companies worldwide for private and white-labeled production. CURE has partnerships in the U.S., China, Mexico, Canada, Israel, and other markets in Europe.
November 18, 2020
Click here:
https://www.biospace.com/article/releases/cur...reholders/
About CURE Pharmaceutical Holding Corp.
CURE Pharmaceutical(R) is the pioneering developer of CUREform(TM), a patented drug delivery platform that offers a number of unique immediate- and controlled-release drug delivery vehicles designed to improve drug efficacy, safety, and patient experience for a wide range of active ingredients.
As a vertically integrated company, CURE's 25,000 square foot, FDA-registered, NSF(R) and cGMP-certified manufacturing facility enables it to partner with pharmaceutical and wellness companies worldwide for private and white-labeled production. CURE has partnerships in the U.S., China, Mexico, Canada, Israel, and other markets in Europe.
(1)
(0)Scroll down for more posts ▼